These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 21508423)
1. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease. Kahrilas PJ; Hughes N; Howden CW Gut; 2011 Nov; 60(11):1473-8. PubMed ID: 21508423 [TBL] [Abstract][Full Text] [Related]
2. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial. Bautista J; Fullerton H; Briseno M; Cui H; Fass R Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202 [TBL] [Abstract][Full Text] [Related]
3. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. van Pinxteren B; Numans ME; Bonis PA; Lau J Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986 [TBL] [Abstract][Full Text] [Related]
4. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670 [TBL] [Abstract][Full Text] [Related]
5. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Dickman R; Emmons S; Cui H; Sewell J; Hernández D; Esquivel RF; Fass R Aliment Pharmacol Ther; 2005 Sep; 22(6):547-55. PubMed ID: 16167971 [TBL] [Abstract][Full Text] [Related]
6. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease. Zerbib F; Belhocine K; Simon M; Capdepont M; Mion F; Bruley des Varannes S; Galmiche JP Gut; 2012 Apr; 61(4):501-6. PubMed ID: 21997546 [TBL] [Abstract][Full Text] [Related]
7. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Sigterman KE; van Pinxteren B; Bonis PA; Lau J; Numans ME Cochrane Database Syst Rev; 2013 May; 2013(5):CD002095. PubMed ID: 23728637 [TBL] [Abstract][Full Text] [Related]
8. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. van Pinxteren B; Numans ME; Bonis PA; Lau J Cochrane Database Syst Rev; 2004 Oct; (4):CD002095. PubMed ID: 15495027 [TBL] [Abstract][Full Text] [Related]
9. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients. Bytzer P; van Zanten SV; Mattsson H; Wernersson B Aliment Pharmacol Ther; 2012 Oct; 36(7):635-43. PubMed ID: 22860764 [TBL] [Abstract][Full Text] [Related]
10. Management of heartburn not responding to proton pump inhibitors. Fass R; Sifrim D Gut; 2009 Feb; 58(2):295-309. PubMed ID: 19136523 [TBL] [Abstract][Full Text] [Related]
11. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. van Pinxteren B; Numans ME; Bonis PA; Lau J Cochrane Database Syst Rev; 2001; (4):CD002095. PubMed ID: 11687139 [TBL] [Abstract][Full Text] [Related]
12. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. van Pinxteren B; Numans ME; Bonis PA; Lau J Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857 [TBL] [Abstract][Full Text] [Related]
13. A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial. Boeckxstaens GE; Beaumont H; Hatlebakk JG; Silberg DG; Björck K; Karlsson M; Denison H Gut; 2011 Sep; 60(9):1182-8. PubMed ID: 21402616 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment of children with gastro-oesophageal reflux. Tighe M; Afzal NA; Bevan A; Hayen A; Munro A; Beattie RM Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008550. PubMed ID: 25419906 [TBL] [Abstract][Full Text] [Related]
15. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease. Kahrilas PJ; Howden CW; Hughes N Am J Gastroenterol; 2011 Aug; 106(8):1419-25; quiz 1426. PubMed ID: 21537361 [TBL] [Abstract][Full Text] [Related]
18. Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients. Kim JH; Sinn DH; Son HJ; Kim JJ; Rhee JC; Rhee PL J Gastroenterol Hepatol; 2009 Sep; 24(9):1504-9. PubMed ID: 19467139 [TBL] [Abstract][Full Text] [Related]
19. Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients? Kahrilas PJ; Boeckxstaens G Gut; 2012 Oct; 61(10):1501-9. PubMed ID: 22684485 [TBL] [Abstract][Full Text] [Related]
20. Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain. Ko SY; Kim SI; Kim JH; Lee JH; Lee KJ; Hong SN; Lee SY; Sung IK; Park HS; Shim CS J Gastroenterol Hepatol; 2012 Sep; 27(9):1484-9. PubMed ID: 22554344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]